. Immunohistochemical detection of CK19 in primary tumors. CK19 expression in primary tumors was assessed by immunohistochemistry in five patients whose SNs were methylation (+) and OSNA (-). The number in the image represents the case number. Scale bars, 100 µm. CK19, cytokeratin 19; SN, sentinel node; OSNA, one-step nucleic acid amplification.
. Fragment size of methylated DNA in SNs. (A) Total DNA in the lysates (100 µl) of three methylation (+)/OSNA (-) SNs was separated into short (<500 bp, dotted line) and long (>500 bp, solid line) fractions by agarose gel electrophoresis. M, size marker. (B) DNA from each fraction was evaluated by RE-dMSP, and the copy number of methylated DNA (copies/assay) in each fraction is presented (grey bar, short; black bar, long). SN, sentinel node; OSNA, one-step nucleic acid amplification; RE-dMSP, dPCR with methylation-specific restriction enzymes. Figure S3 . PIK3CA mutation and RASSF1A methylation in SNs. (A) Correlation between the copy number (copies/assay) of methylated RASSF1A and PIK3CA mutation in SN lysates. (B) The number of methylated RASSF1A-positive and -negative SNs is presented according to the mutation status. RASSF1A, Ras association domain-containing protein 1; SN, sentinel node. 
